GPX4 and neoplasm: And the general palmitoylation inhibitor 2‐BP has been shown to promote ferroptosis.[23] Another research identified ZDHHC8‐mediated palmitoylation of GPX4 at Cys75 site, which suppresses the CD8+ cytotoxic T cell‐induced tumor cell ferroptosis, resulting in immune escape.